Scholarlink

<p>Radioactive iodine-125 (¹²⁵I) seed implantation is an increasingly important brachytherapy approach in cancer treatment. WNT5A is known to promote tumor cell proliferation and migration. This study aimed to elucidate the anticancer mechanisms of ¹²⁵I irradiation in thyroid cancer (TC) cells, with a particular focus on its effects on telomerase activity and the WNT5A/β-catenin signaling pathway.&#xa0;Telomerase activity in thyroid cancer (TC) cells was assessed using the telomeric repeat amplification protocol (TRAP) assay, and telomere length was determined by qPCR. The impact of ¹²⁵I irradiation on cell proliferation, invasion, and migration was measured by MTT, colony formation, Transwell, and wound healing assays. The underlying molecular pathways were investigated both in vitro and in a murine xenograft model.&#xa0;Compared with X-rays, ¹²⁵I irradiation produced markedly stronger cytotoxic effects, decreasing colony formation by ~ 45–60% and reducing telomerase activity by ~ 50%, while doubling apoptosis levels. It also impaired migration, lowering wound-healing closure by ~ 35–40% and reducing Transwell migration and invasion by 40–55%, accompanied by significant downregulation of WNT5A and β-catenin. Exogenous WNT5A partially restored β-catenin expression and improved migration by ~ 25%. In vivo, ¹²⁵I seed implantation reduced tumor volume by ~ 50% and final tumor weight by ~ 45% relative to X-ray treatment.&#xa0;Radioactive ¹²⁵I exerts its anticancer activity through a novel dual mechanism involving the downregulation of telomerase activity and the inactivation of WNT5A/β-catenin signaling. Our findings provide compelling preclinical evidence for the efficacy of ¹²⁵I particle brachytherapy in the treatment of patients with thyroid cancer.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The Impact of 125I Particle Implantation Therapy on Telomerase Activity and WNT5A/β-catenin Signaling Pathway in Thyroid Cancer Cells

  • 期刊论文

  • 发表日期：

    2026年5月25日

查看全文
  • Zhi Zeng,
  • Yan Li,
  • JunFeng Ma,
  • LiYing Dong,
  • SiQi Li

摘要

Radioactive iodine-125 (¹²⁵I) seed implantation is an increasingly important brachytherapy approach in cancer treatment. WNT5A is known to promote tumor cell proliferation and migration. This study aimed to elucidate the anticancer mechanisms of ¹²⁵I irradiation in thyroid cancer (TC) cells, with a particular focus on its effects on telomerase activity and the WNT5A/β-catenin signaling pathway. Telomerase activity in thyroid cancer (TC) cells was assessed using the telomeric repeat amplification protocol (TRAP) assay, and telomere length was determined by qPCR. The impact of ¹²⁵I irradiation on cell proliferation, invasion, and migration was measured by MTT, colony formation, Transwell, and wound healing assays. The underlying molecular pathways were investigated both in vitro and in a murine xenograft model. Compared with X-rays, ¹²⁵I irradiation produced markedly stronger cytotoxic effects, decreasing colony formation by ~ 45–60% and reducing telomerase activity by ~ 50%, while doubling apoptosis levels. It also impaired migration, lowering wound-healing closure by ~ 35–40% and reducing Transwell migration and invasion by 40–55%, accompanied by significant downregulation of WNT5A and β-catenin. Exogenous WNT5A partially restored β-catenin expression and improved migration by ~ 25%. In vivo, ¹²⁵I seed implantation reduced tumor volume by ~ 50% and final tumor weight by ~ 45% relative to X-ray treatment. Radioactive ¹²⁵I exerts its anticancer activity through a novel dual mechanism involving the downregulation of telomerase activity and the inactivation of WNT5A/β-catenin signaling. Our findings provide compelling preclinical evidence for the efficacy of ¹²⁵I particle brachytherapy in the treatment of patients with thyroid cancer.